Vitamin K2 and vitamin D3 work together to help your body absorb and use calcium properly, which is key for both bone and heart health.

This formula combines 180 mcg of vitamin K2 as MK-7 (MenaQ7® PRO), a highly absorbable and well-researched form, with 5,000 IU of vitamin D3. Together, they help guide calcium into your bones where it’s needed most, while supporting healthy arteries.

Vitamin K2 also helps keep calcium from building up in the wrong places, like your arteries and soft tissues, so your body can stay balanced and supported over time.

Because many people don’t get enough vitamins K and D, this daily formula is an easy way to support strong bones and heart health in one supplement.

Benefits

• Helps maintain healthy calcium balance where it matters most

• Promotes strong, healthy bones over time

• Boosts immune function for everyday wellness

• Encourages hearth health and arterial flexibility

Ingredients

Formulated with 180 mcg of vitamin K2 as MK-7 (MenaQ7® PRO) and 5,000 IU of vitamin D3 to support optimal calcium utilization and distribution. This combination helps promote bone mineralization while supporting cardiovascular and immune health.

One capsule contains:
Vitamin D (as Vitamin D3 Cholecalciferol) 5,000 IU.
Vitamin K (Vitamin K2 as Menaquinone-7 (MK-7)) (MenaQ7® PRO) 180 mcg.

Do not consume this product if you are pregnant or nursing. All forms of vitamin K may interact with blood thinning medications. If you are taking such medicines, please consult your physician before taking this product.

Serving

1 Capsule

Take 1 Capsule daily or every other day or as recommended by your healthcare practitioner.

Research

• Supplementing vitamins D3 and K2 at high-concentration
• Vitamin K2 Therapy in Postmenopausal Osteoporosis
• Vitamin K2 Therapy in Type 2 Diabetic Patients
• Vitamin D Therapy in Pneumonia Infection Protocols
• Vitamin D Levels and Cardiovascular Risk
• Vitamin D Supplementation and Improved Respiratory Health
• Vitamin D and Dementia Risk
• Vitamin D3 and K2 Supplementation and Reduced Biomarkers of Bone Fracture Risk